ADMA Biologics, Inc. (ADMA)

NGM – Real Time Price. Currency in USD

9.92

+0.01 (0.15%)

Market open: Aug 12, 2026, 10:43 AM EDT

9.75

-0.15 (-1.56%)

Previous after-hours: Aug 11, 2026, 7:40 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

510M

426M

258M

154M

Cost of goods sold

-218M

-207M

-170M

-120M

Gross Profit

293M

219M

88M

35M

Operating expenses (excl. COGS)

-101M

-80M

-67M

-74M

Operating Income

191M

139M

22M

-40M

Non-operating income, total

-9M

-13M

-50M

-27M

Pretax income

183M

126M

-28M

-66M

Equity in earnings

Taxes

-36M

72M

211K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

147M

198M

-28M

-66M

Discontinued operations

Net income

147M

198M

-28M

-66M

Dilution adjustment

Preferred dividends

ADMA Biologics, Inc. (ADMA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ADMA Biologics, Inc. (ADMA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

ADMA Biologics, Inc. (ADMA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ADMA Biologics, Inc. (ADMA)

Income Statement (Annual)

Income Statement (Annual)